Biofrontera Inc. Common Stock earnings per share and revenue
On 12 nov. 2025, BFRI reported earnings of -0.62 USD per share (EPS) for Q3 25, missing the estimate of -0.59 USD, resulting in a -4.80% surprise. Revenue reached 6.99 million, compared to an expected 7.14 million, with a -2.13% difference. The market reacted with a -8.59% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analystes forecast an EPS of 0.15 USD, with revenue projected to reach 15.85 million USD, implying an baisse of -124.19% EPS, and hausse of 126.79% in Revenue from the last quarter.
FAQ
What were Biofrontera Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Biofrontera Inc. Common Stock reported EPS of -$0.62, missing estimates by -4.8%, and revenue of $6.99M, -2.13% below expectations.
How did the market react to Biofrontera Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -8.59%, changed from $0.97 before the earnings release to $0.89 the day after.
When is Biofrontera Inc. Common Stock expected to report next?
The next earning report is scheduled for 19 mars 2026.
What are the forecasts for Biofrontera Inc. Common Stock's next earnings report?
Based on 4
analystes, Biofrontera Inc. Common Stock is expected to report EPS of $0.15 and revenue of $15.85M for Q4 2025.